HDAC9 and neoplasm: HDAC inhibitors have been reported to kill a variety of tumor cells through diverse mechanisms [20, 21], including disruption of co-repressor complexes, induction of oxidative injury, upregulation of death receptor and ligand expression, generation of lipid second messengers, interference with chaperone protein function, modulation of NFκB activity, mitotic catastrophe, and interference with DNA repair.